Matching Items (2)
Filtering by

Clear all filters

148173-Thumbnail Image.png

Breakdown and classification of skill transfer type between a hockey slap shot and golf drive

Description

There is surprisingly little scientific literature describing whether a hockey slap shot positively or negatively transfers to a driving golf swing. Golf and hockey use a similar kinematic sequence to send the ball / puck towards a target, but does that directly translate to positive skill transfer between the two…

There is surprisingly little scientific literature describing whether a hockey slap shot positively or negatively transfers to a driving golf swing. Golf and hockey use a similar kinematic sequence to send the ball / puck towards a target, but does that directly translate to positive skill transfer between the two sports, or are there other important factors that could result in a negative skill transfer? The aim of this study is to look further into the two kinematic sequences and determine their intertask skill transfer type. A field experiment was conducted, following a specific research design, in order to compare performance between two groups, one being familiar with the skill that may transfer (hockey slapshot) and the other group being unfamiliar. Both groups had no experience in the skill being tested (driving golf swing) and various data was collected as all of the subjects performed 10 golf swings. The results of the data analysis showed that the group with experience in hockey had a higher variability of ball distance and ball speed. There are many factors of a hockey slapshot that are likely to develop a negative intertask skill transfer, resulting in this group's high inconsistency when performing a golf swing. On the other hand, the group with hockey experience also had higher mean club speed, showing that some aspects of the hockey slapshot resulted in a positive skill transfer, aiding their ability to perform a golf swing.
ContributorsLarson, Finn Althea (Author) / Peterson, Daniel (Thesis director) / Cryer, Michael (Committee member) / Materials Science and Engineering Program (Contributor) / Barrett, The Honors College (Contributor)
Created2021-05
132773-Thumbnail Image.png

The Gender Differences in Heart Disease and the Cardiovascular Benefits of Estrogen

Description
Heart disease is the number one killer of men and women in the world. The incidence of cardiovascular disease is known to be much higher in men than women until around the ages of 60-75 years, when the occurrence of the disease becomes approximately equal in both sexes. Additionally, the…

Heart disease is the number one killer of men and women in the world. The incidence of cardiovascular disease is known to be much higher in men than women until around the ages of 60-75 years, when the occurrence of the disease becomes approximately equal in both sexes. Additionally, the occurrence of heart disease is significantly lower in premenopausal women than postmenopausal women. Since men have a higher risk for heart disease than women until 10-15 years after the average age of menopause and postmenopausal women have a higher risk of cardiovascular disease than premenopausal women, it is hypothesized that endogenous estrogen exposure throughout the fertile period of a woman's life postpones the onset of cardiovascular disease. Research shows estrogen has beneficial effects on the cardiovascular system by regulating multiple metabolic processes including lipid metabolism, vasodilation, nitric oxide synthesis, cytochrome c apoptosis, and mitochondrial antioxidant production. Though estrogen has been found to have cardiovascular benefits on individual metabolic processes, the treatment of synthetic estrogen on postmenopausal women and men to reduce the overall risk of heart disease is very controversial. The controversy of synthetic estrogen is partially due to the fact that most studies done using estrogen replacement therapy on postmenopausal women and men resulted in either no effects or harmful effects on the cardiovascular system. Hormone replacement therapy has also been associated with a higher risk of multiple medical conditions, especially venous thromboembolism and breast cancer. This review will explore these topics and consider the costs and benefits of estrogen replacement therapy.
ContributorsWeng, Tina Savanna (Author) / Hyatt, J.P. (Thesis director) / Kingsbury, Jeffrey (Committee member) / Dean, The College of Liberal Arts and Sciences (Contributor) / School of Life Sciences (Contributor) / Dean, W.P. Carey School of Business (Contributor) / Barrett, The Honors College (Contributor)
Created2019-05